Hostname: page-component-848d4c4894-sjtt6 Total loading time: 0 Render date: 2024-06-20T20:50:28.510Z Has data issue: false hasContentIssue false

Effective Antibiotic Conservation by Emergency Antimicrobial Stewardship During a Drug Shortage

Published online by Cambridge University Press:  05 December 2016

Kevin Hsueh*
Affiliation:
Division of Infectious Diseases, Washington University School of Medicine, St. Louis, Missouri
Maria Reyes
Affiliation:
Division of Infectious Diseases, Washington University School of Medicine, St. Louis, Missouri
Tamara Krekel
Affiliation:
Barnes-Jewish Hospital, St. Louis, Missouri
Ed Casabar
Affiliation:
Barnes-Jewish Hospital, St. Louis, Missouri
David J. Ritchie
Affiliation:
Barnes-Jewish Hospital, St. Louis, Missouri St. Louis College of Pharmacy, St. Louis, Missouri
S. Reza Jafarzadeh
Affiliation:
Division of Infectious Diseases, Washington University School of Medicine, St. Louis, Missouri
Amanda J. Hays
Affiliation:
Center for Clinical Excellence, BJC Healthcare, St. Louis, Missouri
Michael A. Lane
Affiliation:
Division of Infectious Diseases, Washington University School of Medicine, St. Louis, Missouri Center for Clinical Excellence, BJC Healthcare, St. Louis, Missouri
Michael J. Durkin
Affiliation:
Division of Infectious Diseases, Washington University School of Medicine, St. Louis, Missouri Institute for Public Health, Washington University, St. Louis, Missouri.
*
Address correspondence to Kevin Hsueh, MD, Division of Infectious Diseases, Washington University School of Medicine, 660 S. Euclid Ave., Campus Box 8051, St. Louis, MO, 63110 (khsueh@wustl.edu).

Abstract

We present the first description of an antimicrobial stewardship program (ASP) used to successfully manage a multi-antimicrobial drug shortage. Without resorting to formulary restriction, meropenem utilization decreased by 69% and piperacillin-tazobactam by 73%. During the shortage period, hospital mortality decreased (P=.03), while hospital length of stay remained unchanged.

Infect Control Hosp Epidemiol 2017;38:356–359

Type
Concise Communications
Copyright
© 2016 by The Society for Healthcare Epidemiology of America. All rights reserved 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1. Quadri, F, Mazer-Amirshahi, M, Fox, ER, et al. Antibacterial drug shortages from 2001 to 2013: implications for clinical practice. Clin Infect Dis 2015;60:17371742.CrossRefGoogle ScholarPubMed
2. Gupta, DK, Huang, S-M. Drug shortages in the United States: a critical evaluation of root causes and the need for action. Clin Pharmacol Ther 2013;93:133135.Google Scholar
3. Kuehn, BM. Despite curbing new drug shortages, shortfall of drugs a persistent problem. JAMA 2013;309:532533.Google Scholar
4. Paskovaty, A, Lucarelli, CD, Patel, P, Ryan, M, Seyboth, B, Thackray, J, et al. Antimicrobial stewardship efforts to manage a pentamidine shortage. Am J Health Syst Pharm 2014;71:20142018.Google Scholar
5. Griffith, MM, Patel, JA, Sutton, SH, et al. Prospective approach to managing antimicrobial drug shortages. Infect Control Hosp Epidemiol 2012;33:745752.Google Scholar
6. Antimicrobial use and resistance (AUR) module. Centers for Disease Control and Prevention website. http://www.cdc.gov/nhsn/pdfs/pscmanual/11pscaurcurrent.pdf. Updated January 2016. Accessed November 2, 2016.Google Scholar
7. Polk, RE, Fox, C, Mahoney, A, Letcavage, J, MacDougall, C. Measurement of adult antibacterial drug use in 130 US hospitals: comparison of defined daily dose and days of therapy. Clin Infect Dis 2007;44:664670.Google Scholar
8. RED BOOK Online® [online database]. Truven Health Analytics. http://www.micromedexsolutions.com/. Accessed May 5, 2016.Google Scholar
9. Valiquette, L, Cossette, B, Garant, M-P, Diab, H, Pepin, J. Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of Clostridium difficile-associated disease caused by the hypervirulent NAP1/027 strain. Clin Infect Dis 2007;45:S112S121.Google Scholar
10. Bantar, C, Sartori, B, Vesco, E, et al. A hospitalwide intervention program to optimize the quality of antibiotic use: impact on prescribing practice, antibiotic consumption, cost savings, and bacterial resistance. Clin Infect Dis 2003;37:180186.Google Scholar
Supplementary material: Image

Hsueh supplementary material

Figure S1

Download Hsueh supplementary material(Image)
Image 2.5 MB
Supplementary material: Image

Hsueh supplementary material

Figure S2

Download Hsueh supplementary material(Image)
Image 842.6 KB